Biomaxima SA (944) Stock Statistics & Valuation Metrics
Total Valuation
Biomaxima SA has a market cap or net worth of EUR 8.92M. The enterprise value is EUR 56.29T.
- Market Cap
- EUR 8.92M
- Enterprise Value
- EUR 56.29T
Share Statistics
Biomaxima SA has 4,193,118 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 4,193,118
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Biomaxima SA’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is -0.11%.
- Return on Equity (ROE)
- 0.00
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- -0.11%
- Return on Capital Employed (ROCE)
- -0.00
- Revenue Per Employee
- 425.90K
- Profits Per Employee
- 734.266
- Employee Count
- 143
- Asset Turnover
- 0.79
- Inventory Turnover
- 4.35
Valuation Ratios
The current PE Ratio of Biomaxima SA is 48.91. Biomaxima SA’s PEG ratio is -0.19.
- PE Ratio
- 48.91
- PS Ratio
- 0.65
- PB Ratio
- 0.81
- Price to FCF
- 99.93
- Price to Operating Cash Flow
- 34.06
- PEG Ratio
- -0.19
Income Statement
In the last 12 months, Biomaxima SA had revenue of 60.90M and earned 105.00K in profits. Earnings per share was 0.03.
- Revenue
- 60.90M
- Gross Profit
- 1.67M
- Operating Income
- -135.00K
- Pretax Income
- 188.00K
- Net Income
- 105.00K
- EBITDA
- 3.57M
- Earnings Per Share (EPS)
- 0.03
Cash Flow
In the last 12 months, operating cash flow was 1.16M and capital expenditures -762,000, giving a free cash flow of 394.00K billion.
- Operating Cash Flow
- 1.16M
- Free Cash Flow
- 394.00K
- Free Cash Flow per Share
- 0.09
Dividends & Yields
Biomaxima SA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 1.00%
- Earnings Yield
- 2.05%
Stock Price Statistics
- Beta
- 0.22
- 52-Week Price Change
- -30.96%
- 50-Day Moving Average
- 1.94
- 200-Day Moving Average
- 2.13
- Relative Strength Index (RSI)
- 14.02
- Average Volume (3m)
- ―
Financial Position
Biomaxima SA as a current ratio of 1.74, with Debt / Equity ratio of 30.07%
- Current Ratio
- 1.74
- Quick Ratio
- 0.83
- Debt to Market Cap
- 0.25
- Net Debt to EBITDA
- 3.56
- Interest Coverage Ratio
- -0.11
Taxes
In the past 12 months, Biomaxima SA has paid 83.00K in taxes.
- Income Tax
- 83.00K
- Effective Tax Rate
- 0.44
Enterprise Valuation
Biomaxima SA EV to EBITDA ratio is 13.54, with an EV/FCF ratio of 139.21.
- EV to Sales
- 0.90
- EV to EBITDA
- 13.54
- EV to Free Cash Flow
- 139.21
- EV to Operating Cash Flow
- 47.45
Balance Sheet
Biomaxima SA has EUR 1.20M in cash and marketable securities with EUR 16.67M in debt, giving a net cash position of -EUR 15.48M billion.
- Cash & Marketable Securities
- EUR 1.20M
- Total Debt
- EUR 16.67M
- Net Cash
- -EUR 15.48M
- Net Cash Per Share
- -EUR 3.69
- Tangible Book Value Per Share
- EUR 11.32
Margins
Gross margin is 2.37%, with operating margin of -0.60%, and net profit margin of 1.33%.
- Gross Margin
- 2.37%
- Operating Margin
- -0.60%
- Pretax Margin
- 1.62%
- Net Profit Margin
- 1.33%
- EBITDA Margin
- 6.68%
- EBIT Margin
- 0.35%
Analyst Forecast
The average price target for Biomaxima SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 6.73%
- EPS Growth Forecast
- 16.03%
